TrialFrontiers in immunology2026

A multicenter randomized study: safety of an optimized accelerated house dust mite immunotherapy for patients with allergic rhinitis in China (PERFECT study).

Guangyao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.